LakePharma buys Hopkinton facility for $4.5M
Google
LakePharma has purchased this Hopkinton building for $4.5 million.
The California bioscience company once considered to be the anchor of a Worcester biomanufacturing campus is planning to open a new facility in a 69,000-square-foot Hopkinton building.
The property, at 35 South St., will be developed for LakePharmas’ microbiomanufacturing center, where the company will conduct phase 1 clinical trials.
According to the Middlesex County Registry of Deeds, the company purchased the property from Michigan-based property managers Midway Corp. for just over $4.5 million in December.
The company plans to add about 100 jobs at the site by 2020, LakePharma said in a press release Monday.
When ready, the site will support the company’s assay development, bioanalytical and process development and quality control services.
The company was once a prospective anchor tenant for a large biomanufacturing campus under development by the Worcester Business Development Corp. at the former Worcester State Hospital site, but pulled out of the project in September.
LakePharma still operates a facility in Worcester at the Worcester Polytechnic Institute campus and plans to double the size of that operation this year.
The company in December said it raised $30 million to open additional locations in Massachusetts and California, but didn’t disclose the location until Monday.
In a statement, LakePharma CEO Hua Tu said the new facility will allow for fully integrated contract development and manufacturing organization capabilities.
The site is a short drive to Boston and the surrounding area, where a large cluster of biotechs and LakePharma customers exist.
“We will soon be able to provide our clients and partners with the end-to-end services they demand,” Tu said.
According to the Massachusetts Biotechnology Council, the building was previously occupied by Bristol-Myers Squibb and Olympus Biotech before that.
WBJ Web Partners
Most Recent
0 Comments